T1	Treatment 11 74	adjuvant dose-dense chemotherapy with paclitaxel and epirubicin
T2	Treatment 159 222	adjuvant dose-dense chemotherapy with paclitaxel and epirubicin
T3	Treatment 490 620	6 cycles of chemotherapy with intravenous administration of paclitaxel (175 mg/m2, on D3) and epirubicin (60 mg/m2, on Dl and D2).
T4	Treatment 625 680	dose-dense group had repeated treatment every two weeks
T5	Treatment 692 736	regular group repeated it every three weeks.
T6	Treatment 737 785	G-CSF was used in a dose of 3 microg/kg on D5-D9
T7	Treatment 1714 1777	Adjuvant dose-dense chemotherapy with paclitaxel and epirubicin
